Skip to main content
    H

    Henry Schein Inc (HSIC)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ

    $84.96
    -1.26 (-1.46%)

    Market Cap: $9.53B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Henry Schein Inc (HSIC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Henry Schein are Cardinal Health (CAH), McKesson (MCK) and Hinge Health (HNGE). Henry Schein trades at 15.5x earnings, against a median of 19.6x for the 10 of these companies with a P/E. By market cap, Henry Schein ranks 10th of the 13 companies on this page; McKesson (MCK) is the largest at $127.33B.

    Peer Comparison

    HSIC's ROIC of 7.7% is below the peer median of 10.6%, and its revenue growth of 4.0% is below the median of 5.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Henry Schein (HSIC)$9.53B15.5x0.7x3.1%7.7%4.0%0.00%
    Cardinal Health Inc (CAH)$64.97B23.7x0.3x0.7%37.6%5.5%0.73%
    McKesson Corporation (MCK)$127.33B25.9x0.3x1.1%108.2%7.6%0.34%
    Hinge Health, Inc. (HNGE)$9.38B56.9x12.2x21.0%N/A52.4%0.00%
    Universal Health Services Inc (UHS)$11.19B8.7x0.6x8.0%11.8%5.3%0.40%
    Smith & Nephew SNATS Inc (SNN)$13.09BN/A2.1x10.1%8.0%4.6%2.56%
    Oscar Health Inc (OSCR)$9.65B12.9x0.6x4.9%32.7%72.1%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    Integer Holdings Corp (ITGR)$4.31B21.5x2.4x5.7%4.7%-3.9%0.00%
    Solventum Corp. (SOLV)$15.14B12.6x1.9x1.9%3.9%-7.0%0.00%
    HealthEquity Inc (HQY)$8.56B25.7x6.4x17.4%9.4%7.6%0.00%
    Baxter International Inc (BAX)$13.35B13.2x1.1x-6.2%0.4%5.0%0.16%
    Halozyme Therapeutics Inc (HALO)$11.43B17.8x6.1x26.9%15.8%39.2%0.00%
    Peer median$11.37B19.6x1.9x5.3%10.6%5.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Henry Schein, ranked by how closely their business, size, sector and industry match. They span 7 industries, with no more than 2 of the 12 in any one.

    CompanyAboutPeers
    Cardinal Health Inc (CAH)Medical Distribution
    Cardinal Health, Inc. is an American multinational health care services company.
    CAH competitors
    McKesson Corporation (MCK)Medical Distribution
    McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies...
    MCK competitors
    Hinge Health, Inc. (HNGE)Health Information Services
    Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
    HNGE competitors
    Universal Health Services Inc (UHS)Medical Care Facilities
    UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota.
    UHS competitors
    Smith & Nephew SNATS Inc (SNN)Medical Devices
    Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom.
    Oscar Health Inc (OSCR)Healthcare Plans
    Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States.
    OSCR competitors
    Summit Therapeutics PLC (SMMT)Biotechnology
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    Integer Holdings Corp (ITGR)Medical Devices
    Integer Holdings Corporation is an outsourced manufacturer of medical devices in the United States, Puerto Rico, Costa Rica, and internationally.
    ITGR competitors
    Solventum Corp. (SOLV)Medical Instruments & Supplies
    Solventum Corporation, a healthcare company, engages in the developing, manufacturing...
    SOLV competitors
    HealthEquity Inc (HQY)Health Information Services
    HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.
    HQY competitors
    Baxter International Inc (BAX)Medical Instruments & Supplies
    Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois.
    BAX competitors
    Halozyme Therapeutics Inc (HALO)Biotechnology
    Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.
    HALO competitors

    Frequently Asked Questions About HSIC

    Who are Henry Schein's main competitors?

    The companies most similar to Henry Schein include Cardinal Health (CAH), McKesson (MCK), Hinge Health (HNGE), Universal Health Services (UHS) and Smith & Nephew SNATS (SNN), listed from the closest match.

    Who is Henry Schein's biggest competitor?

    McKesson (MCK) is the largest of the similar companies at $127.33B; Cardinal Health (CAH) is the closest match by business profile, size, sector and industry.

    How does HSIC stock compare with its competitors?

    HSIC's P/E is 15.5x against a peer median of 19.6x; its P/S is 0.7x against a peer median of 1.9x; its net margin is 3.1% against a peer median of 5.3%.

    Which of Henry Schein's competitors pays a higher dividend?

    Henry Schein pays no dividend. Smith & Nephew SNATS (SNN), Cardinal Health (CAH), Universal Health Services (UHS), McKesson (MCK) and Baxter International (BAX) have higher forward dividend yields; Smith & Nephew SNATS (SNN) has the highest at 2.56%.

    Is Henry Schein bigger than its competitors?

    No. Henry Schein is 10th by market cap among the 13 companies on this page; the largest is McKesson (MCK) at $127.33B.